NCT05240040 2026-03-23
Treat Primary and Metastatic Liver Tumors
Methodist Health System
Withdrawn
Clinical Trials
100 trialsNCT06282185 2026-03-23
Superman
Canisius-Wilhelmina Hospital
Phase NA Withdrawn
NCT06626256 2025-12-24
STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma
City of Hope Medical Center
Phase 1 Withdrawn
NCT01861938 2025-10-02
Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients
Hadassah Medical Organization
Phase 2/3 Withdrawn
NCT06676917 2025-08-08
TUXEDO-5
MedSIR
Phase 2 Withdrawn
NCT04615884 2025-07-28
CH:II
Lady Davis Institute
Phase NA Withdrawn
NCT05222308 2025-07-08
Advanced Planning for Online Accounts and Data
University of Colorado, Denver
Phase NA Withdrawn
NCT06416436 2025-06-29
Dose-escalation Study of Ultra-high Dose Ablative Radiosurgery With Immunotherapy for Bulky Metastatic Cancer Patients
University of Kansas Medical Center
Phase 1 Withdrawn
NCT04820894 2025-05-23
Perception of Cure Among Patients With Metastatic Cancer
City of Hope Medical Center
Withdrawn
NCT05653661 2025-01-07
Nab-Paclitaxel/STI-3031 Complex (AP160-Complex) for the Treatment of Advanced or Metastatic Solid Tumors
Mayo Clinic
Phase 1 Withdrawn
NCT03003195 2024-09-03
The P10s-PADRE Basket Trial: Vaccination of Metastatic Cancer Patients
University of Arkansas
Phase 2 Withdrawn
NCT05574504 2024-08-01
Phase II Trial of Lurbinectedin Combined With Avelumab as Switch Maintenance Firstline Therapy
AdventHealth
Phase 2 Withdrawn
NCT04931420 2024-07-31
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
University of Chicago
Phase 2 Withdrawn
NCT06057636 2024-05-10
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
The University of Tennessee, Knoxville
Phase NA Withdrawn
NCT03841747 2024-03-12
PELICAN
Queen Mary University of London
Phase 2 Withdrawn
NCT03671720 2024-02-07
Personalized Vaccine Generated by Autologous Dendritic Cells Pulsed With Autologous Whole Tumor Cell Lysate Treat Advanced Solid Tumor Patients With High Tumor Mutation Burden
Capital Medical University
Phase EARLY_PHASE1 Withdrawn
NCT05948462 2023-12-13
NSCLC
SCRI Development Innovations, LLC
Phase 2 Withdrawn
NCT04602117 2023-11-18
ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer
QuantumLeap Healthcare Collaborative
Phase 1 Withdrawn
NCT05728372 2023-10-10
64Cu-DOTA Pembrolizumab for Imaging Metastatic Solid Tumors in Patients Receiving Stereotactic Body Radiation
City of Hope Medical Center
Phase EARLY_PHASE1 Withdrawn
NCT04901299 2023-08-01
HER2-Signal
Massachusetts General Hospital
Phase 2 Withdrawn
NCT04896320 2023-06-22
2019-101826
Providence Health & Services
Phase 1/2 Withdrawn
NCT05060653 2023-05-18
BLEND-II
UMC Utrecht
Phase NA Withdrawn
NCT05472220 2022-12-27
Alpelisib in Combination With Carboplatin in Patients With Solid Tumors and HPV-Positive Squamous Cell Carcinoma
University of California, San Francisco
Phase 1 Withdrawn
NCT01436292 2022-11-17
Halburns
Centre hospitalier de l'Université de Montréal (CHUM)
Phase 4 Withdrawn
NCT00936832 2022-08-30
Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by Surgery
Federation Francophone de Cancerologie Digestive
Phase 2 Withdrawn
NCT04895046 2022-06-29
Maintenance Niraparib and Dostarlimab in Advanced Cholangiocarcinoma
Hoosier Cancer Research Network
Phase 2 Withdrawn
NCT05010096 2022-05-27
BAY1895344 and Copanlisib for the Treatment of Molecularly Selected Patients With Advanced Solid Tumors
M.D. Anderson Cancer Center
Phase 1 Withdrawn
NCT03868423 2022-02-18
Brigatinib in Treating Patients With ALK and ROS1 Gene Alterations and Locally Advanced or Metastatic Solid Cancers
Ohio State University Comprehensive Cancer Center
Phase 2 Withdrawn
NCT02567643 2022-01-11
Stereotactic Radiosurgery (SRS) for Multiple CNS Mets
The Cooper Health System
Phase NA Withdrawn
NCT04105062 2021-12-09
LS301 Uptake in Tumors of Patients Undergoing Liver, Pancreas, or Gastric Surgery
Washington University School of Medicine
Phase 1/2 Withdrawn
NCT04001101 2021-11-30
Anti-PD-1 +/- RT for MSI-H Solid Tumors
University of Colorado, Denver
Phase 2 Withdrawn
NCT04498520 2021-05-18
Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer
University of California, San Francisco
Phase 1 Withdrawn
NCT03849742 2021-05-14
Ride to Care - Quality of Life With Transportation for RT
University of California, San Francisco
Phase NA Withdrawn
NCT04398927 2021-02-04
Systemic Chemotherapy Plus PD-1 for Metastasis ICC
Sun Yat-sen University
Phase 2 Withdrawn
NCT02503280 2020-10-22
TAC-HFT-II
University of Miami
Phase 1/2 Withdrawn
NCT04184518 2020-06-02
CEDUVEAL-M
Grupo Español Multidisciplinar de Melanoma
Phase 2 Withdrawn
NCT03323424 2020-01-30
IRAM
Institut de Cancérologie de la Loire
Phase 2 Withdrawn
NCT02466568 2019-09-09
Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung
H. Lee Moffitt Cancer Center and Research Institute
Phase 1/2 Withdrawn
NCT02300935 2019-05-30
Study of Trametinib and Nab-paclitaxel in Patients With Melanoma
SCRI Development Innovations, LLC
Phase 1 Withdrawn
NCT02581501 2019-04-18
Prospective Phase I Study of GAX for Metastatic Pancreatic Cancer
Stamford Hospital
Phase 1 Withdrawn
NCT03323710 2019-01-09
Study of Propranolol Plus Sunitinib in First-line Treatment of Metastatic Renal Cell Carcinoma
Military Institute od Medicine National Research Institute
Phase 2 Withdrawn
NCT00005030 2018-11-14
SCH 66336 Before Surgery in Treating Patients With Colorectal Cancer That Has Metastasized to the Liver
M.D. Anderson Cancer Center
Phase 1 Withdrawn
NCT03226236 2018-11-13
RENALVax-2
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 2 Withdrawn
NCT03029416 2018-10-15
Two Radiation Dose Schedules of SBRT to Lung Metastases < 5cm in Dimension
University of Kentucky
Phase 2 Withdrawn
NCT02967770 2018-09-11
PanCAN
Georgetown University
Phase 2 Withdrawn
NCT00406120 2018-06-26
Validation of a Molecular Prognostic Test for Eye Melanoma
Washington University School of Medicine
Withdrawn
NCT02962804 2018-03-05
Combination Radiation and PD-1 Inhibition in Metastatic or Recurrent Renal Cell Carcinoma (RCC)
University of Kansas Medical Center
Phase 2 Withdrawn
NCT02105350 2018-02-19
A Study of MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer
University Health Network, Toronto
Phase 1 Withdrawn
NCT02496832 2018-02-19
A Study of Hypoxia Imaging in Advanced Pancreatic Cancer Patients Being Treated With Gemcitabine and TH-302 or TH-302 Placebo
University Health Network, Toronto
Phase NA Withdrawn
NCT01736722 2018-01-17
MRI-Guided LITT for Treatment Metastatic Brain Tumors
The Methodist Hospital Research Institute
Phase NA Withdrawn